Acorda Therapeutics (ACOR) Tops Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts ACOR Hot Sheet
Price: $0.66 --0%
Financial Fact:
Loss before taxes: -10.01M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Loss before taxes: -10.01M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Acorda Therapeutics (NASDAQ: ACOR) reported Q2 EPS of $0.19, $0.07 better than the analyst estimate of $0.12. Revenue for the quarter came in at $65.28 million versus the consensus estimate of $66.29 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
- Traws Pharma (TRAW) Tops Q2 EPS by 27c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
